top of page
NDC | HCPCS | HCPCS Description | NDC Label | Route of Administration |
|---|---|---|---|---|
62756-0238-86 | None | CAPECITABINE, 150 MG, ORAL | CAPECITABINE (USP,FILM COATED) 150 MG | PO |
62756-0239-20 | None | CAPECITABINE, 500 MG, ORAL | CAPECITABINE (USP,FILM COATED) 500 MG | PO |
62756-0240-64 | Q0162 | ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | ONDANSETRON 4 MG | PO |
62756-0277-02 | J7605 | ARFORMOTEROL, INHALATION SOLUTION, FDA APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE FORM, 15 MICROGRAMS | ARFORMOTEROL TARTRATE (30X2ML,PF,LATEX-FREE) 15 MCG/2 ML | IH |
62756-0277-02 | J7605 | ARFORMOTEROL, INHALATION SOLUTION, FDA APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE FORM, 15 MICROGRAMS | ARFORMOTEROL TARTRATE (30X2ML,PF,LATEX-FREE) 15 MCG/2 ML | IH |
62756-0277-03 | J7605 | ARFORMOTEROL, INHALATION SOLUTION, FDA APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE FORM, 15 MICROGRAMS | ARFORMOTEROL TARTRATE (60X2ML,PF,LATEX-FREE) 15 MCG/2 ML | IH |
62756-0277-03 | J7605 | ARFORMOTEROL, INHALATION SOLUTION, FDA APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE FORM, 15 MICROGRAMS | ARFORMOTEROL TARTRATE (60X2ML,PF,LATEX-FREE) 15 MCG/2 ML | IH |
62756-0321-60 | J9198 | INJECTION, GEMCITABINE HYDROCHLORIDE, (INFUGEM), 100 MG | INFUGEM (LATEX-FREE) 1600 MG/160 ML | IV |
62756-0321-60 | J9199 | INJECTION, GEMCITABINE HYDROCHLORIDE (INFUGEM), 200 MG | INFUGEM (LATEX-FREE) 1600 MG/160 ML | IV |
62756-0356-64 | Q0162 | ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | ONDANSETRON 8 MG | PO |
62756-0356-66 | Q0162 | ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | ONDANSETRON 8 MG | PO |
62756-0438-60 | J9198 | INJECTION, GEMCITABINE HYDROCHLORIDE, (INFUGEM), 100 MG | INFUGEM (LATEX-FREE) 1700 MG/170 ML | IV |
HCPCS Code | Description | Billing Unit | SA Type |
|---|---|---|---|
A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | Each | N |
A7006 | Administration set, with small volume filter pneumatic nebulizer | Each | N |
A7007 | Large voume nebulizer, disposable, unfilled, used with aerosol compressor | Each | N |
A7008 | Large volume nebulizer, disposable, Prefilled, used with aerosol compressor | Each | N |
bottom of page